Primary percutaneous coronary intervention vs. fibrinolytic therapy for acute ST-elevation myocardial infarction in
1Department of Cardiovascular Medicine, Cleveland Clinic Foundation, Cleveland, OH 44195, USA. topole@ccf.org.
Insights
Elderly patients with ST-elevation myocardial infarction often miss reperfusion therapy. Primary percutaneous coronary intervention is preferred over fibrinolysis if timely, but optimal delay times require further study.
Area of Science:
- Cardiology
- Geriatric Medicine
- Interventional Cardiology
Background:
- Advanced age correlates with poorer outcomes in acute ST-elevation myocardial infarction (STEMI).
- Elderly STEMI patients frequently do not receive reperfusion therapy.
- Age-related increased risk of intracranial hemorrhage with fibrinolytic therapy.
Purpose of the Study:
- To evaluate reperfusion strategies for elderly patients with acute ST-elevation myocardial infarction.
- To compare primary percutaneous coronary intervention (PCI) with fibrinolytic therapy in older adults.
- To determine the optimal timing for primary PCI versus fibrinolysis.
Main Methods:
- Review of current treatment guidelines and clinical evidence.
- Analysis of risks and benefits of reperfusion therapies in elderly STEMI patients.
- Discussion of the impact of adjunctive stenting on coronary angioplasty safety.
Main Results:
- Primary PCI is the preferred reperfusion strategy for elderly STEMI patients.
- Timeliness of primary PCI is crucial for its benefit over fibrinolysis.
- The threshold for acceptable delay in primary PCI compared to fibrinolysis remains undefined.
Conclusions:
- Primary PCI offers a safer and more effective reperfusion strategy for elderly STEMI patients.
- Minimizing delays in primary PCI is essential for optimal patient outcomes.
- Further research is needed to establish the break-even delay for primary PCI versus fibrinolysis.
Abstract:
Advanced age is associated with worse prognosis among patients with acute ST-elevation myocardial infarction. Many eligible elderly patients with acute ST-elevation myocardial infarction, however, do not receive any reperfusion therapy at all. The risk of intracranial hemorrhage complicating fibrinolytic therapy increases with age. Furthermore, routine adjunctive stenting has made coronary angioplasty safer. In total, primary percutaneous coronary intervention is the preferred reperfusion strategy among elderly patients with acute ST-elevation myocardial infarction, provided that it can be performed without excessive delay. The break-even incremental delay with primary percutaneous coronary intervention compared with fibrinolytic therapy is not clear at this point and will need to be elucidated by future investigation.
Related Concept Videos
Acute Coronary Syndrome I: Introduction
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Peripheral Artery Disease III: Interprofessional Care
Venous Thrombosis III: Interprofessional Care
Acute Coronary Syndrome III: Diagnostic Studies
